SNCA and Parkinson disease: However, this month [03(2022)] first positive results were reported at the AD/PD Conference for a new PET tracer developed by AC Immune to distinguish multiple system atrophy (MSA) from healthy controls and patients with other forms of α-synuclein (PD, DLB).